NCT01068782 2026-02-25Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseExelixisPhase 2 Terminated19 enrolled 10 charts
NCT05039281 2025-12-19Atezolizumab and Cabozantinib for the Treatment of Recurrent GlioblastomaM.D. Anderson Cancer CenterPhase 1/2 Recruiting6 enrolled
NCT02885324 2022-10-06Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in ChildrenIndiana UniversityPhase 2 Terminated4 enrolled 6 charts